Large Brazilian Stem Cell Trial

Following on from more modest trials of first generation stem cell therapies for heart disease, a 1200-member trial is to begin in Brazil. "As for the patients, they will certainly have better quality of life with less need to use medications and fewer hospital visits. And it is also estimated that the new treatment could save as many as 200,000 lives over a three year period." Accumulated damage to heart tissue kills many, many people - approximately 2000 each and every day in the US alone. The heart is a good place to start on regenerative medicine. It is a comparatively unsophisticated organ, requiring less tailored, complex therapies - and any effective therapy will bring health benefits and additional years of healthy life to large numbers of people.



Post a comment; thoughtful, considered opinions are valued. New comments can be edited for a few minutes following submission. Comments incorporating ad hominem attacks, advertising, and other forms of inappropriate behavior are likely to be deleted.

Note that there is a comment feed for those who like to keep up with conversations.